0000820081-14-000005.txt : 20140220 0000820081-14-000005.hdr.sgml : 20140220 20140220153618 ACCESSION NUMBER: 0000820081-14-000005 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140218 FILED AS OF DATE: 20140220 DATE AS OF CHANGE: 20140220 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CAMBREX CORP CENTRAL INDEX KEY: 0000820081 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222476135 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE MEADOWLANDS PLZ CITY: E RUTHERFORD STATE: NJ ZIP: 07073 BUSINESS PHONE: 2018043000 MAIL ADDRESS: STREET 1: ONE MEADOWLANDS PLAZA CITY: E. RUTHERFORD STATE: NJ ZIP: 07073 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SARGEN GREGORY CENTRAL INDEX KEY: 0001227835 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10638 FILM NUMBER: 14629389 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2014-02-18 0000820081 CAMBREX CORP CBM 0001227835 SARGEN GREGORY ONE MEADOWLANDS PLAZA EAST RUTHERFORD NJ 07073 0 1 0 0 EVP & CFO Common Stock 2014-02-18 4 M 0 8500 13.75 A 41819 D Common Stock 2014-02-18 4 M 0 30000 5.51 A 71819 D Common Stock 2014-02-18 4 S 0 38500 21.662 D 33319 D Stock Option (Right to Buy) 13.75 2014-02-18 4 M 0 8500 0 D 2014-07-26 Common Stock 8500 0 D Stock Option (Right to Buy) 5.51 2014-02-18 4 M 0 30000 0 D 2015-04-23 Common Stock 30000 50000 D The option, representing a right to purchase a total of 8,500 shares, became exercisable in four equal annual installments beginning on July 26, 2008, which was the first anniversary of the date on which the option was granted. The option, representing a right to purchase a total of 100,000 shares, became exercisable in four equal annual installments beginning on April 23, 2009, which was the first anniversary of the date on which the option was granted. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.45 to $21.86, inclusive. The reporting person undertakes to provide to Cambrex Corporation, any security holder of Cambrex Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4. Linda Kresse for Gregory P. Sargen by POA 2014-02-20